LOINCActiveBoth

LOINC Code 101515-5: Equine herpesvirus 1 neuropathogenic G2254 variant DNA NAA+probe (Specimen) [ThreshNum]

101515-5 is a LOINC code used to identify Equine herpesvirus 1 neuropathogenic G2254 variant DNA NAA+probe (Specimen) [ThreshNum] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Equine herpesvirus 1 neuropathogenic G2254 variant DNA. It is commonly used with the system or sample type XXX.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Equine herpesvirus 1 neuropathogenic G2254 variant DNA. It is commonly used with the system or sample type XXX.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Probe.amp.tar

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Equine herpesvirus 1 neuropathogenic G2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detection
  • Equine herpesvirus 1 neuropathogenic G2254 variant DNA
  • This mutation is a single nucleotide adenine to guanine substitution located at nucleotide 2254, corresponding to an asparagine to aspartic acid substitution. Includes a variety of specimen types such as organs, tissues, isolates and others as determined by the diagnostician.
  • 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV1; EHV-1; EHV1 G2254; EHV1 G2254 DNA; Equid; Equid alphaherpesvirus 1; Equin; Equine abortion herpesvirus; Equine rhinopneumonitis; Herpes virus; i; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Equine herpesvirus 1 neuropathogenic G2254 variant DNA NAA+probe (Specimen) [ThreshNum]Equine herpesvirus 1 neuropathogenic G2254 variant DNA [Cycle Threshold #] in Specimen by NAA with probe detectionEHV1 G2254 DNA Ct Spec Qn NAA+probeEquine herpesvirus 1 neuropathogenic G2254 variant DNAMICROEquine herpesvirus 1 neuropathogenic G2254 variant, SpecimenThreshNum

Frequently asked questions

Code details

Code101515-5
SystemLOINC
Display nameEquine herpesvirus 1 neuropathogenic G2254 variant DNA NAA+probe (Specimen) [ThreshNum]
DescriptionEquine herpesvirus 1 neuropathogenic G2254 variant DNA
Short nameEHV1 G2254 DNA Ct Spec Qn NAA+probe
ComponentEquine herpesvirus 1 neuropathogenic G2254 variant DNA
PropertyThreshNum
TimingPt
System (specimen)XXX
ScaleQn
MethodProbe.amp.tar
ClassMICRO
Example unitsCt
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.74
Last changed2.75

Consumer names

Equine herpesvirus 1 neuropathogenic G2254 variant, Specimen

Part names

Equine herpesvirus 1 neuropathogenic G2254 variant DNAThreshNumPtXXXQnProbe.amp.tarPoint in time (spot)Nucleic acid amplification with probe detection

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.